- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 241/38 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
Patent holdings for IPC class C07D 241/38
Total number of patents in this class: 194
10-year publication summary
|
14
|
12
|
16
|
12
|
14
|
17
|
9
|
6
|
13
|
3
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| FUJIFILM Corporation | 29399 |
9 |
| Semiconductor Energy Laboratory Co., Ltd. | 11416 |
8 |
| Cytokinetics, Inc. | 277 |
8 |
| Merck Patent GmbH | 5823 |
6 |
| Samsung Display Co., Ltd. | 34798 |
5 |
| Beijing Tide Pharmaceutical Co. Ltd. | 92 |
5 |
| Otsuka Pharmaceutical Co., Ltd. | 1493 |
5 |
| Sony Corporation | 31036 |
4 |
| Merck Sharp & Dohme LLC | 3741 |
4 |
| Idemitsu Kosan Co., Ltd. | 4220 |
3 |
| Fondazione Istituto Italiano di Tecnologia | 583 |
3 |
| Gilead Sciences, Inc. | 2037 |
3 |
| Intra-Cellular Therapies, Inc. | 411 |
3 |
| Kyulux, Inc. | 234 |
3 |
| Signal Pharmaceuticals, LLC | 179 |
3 |
| Ogeda S.A. | 35 |
3 |
| LG Display Co., Ltd. | 13518 |
2 |
| Boehringer Ingelheim International GmbH | 4648 |
2 |
| Commissariat à l'énergie atomique et aux energies alternatives | 10912 |
2 |
| Takeda Pharmaceutical Company Limited | 2709 |
2 |
| Other owners | 111 |